Search by Drug Name or NDC

    NDC 00173-0547-00 MEPRON 750 mg/5mL Details

    MEPRON 750 mg/5mL

    MEPRON is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is ATOVAQUONE.

    Product Information

    NDC 00173-0547
    Product ID 0173-0547_a88a003d-2672-4782-8d24-62b2bf6e64ba
    Associated GPIs 16400020001820
    GCN Sequence Number 023399
    GCN Sequence Number Description atovaquone ORAL SUSP 750 MG/5ML ORAL
    HIC3 W4K
    HIC3 Description ANTIPROTOZOAL DRUGS,MISCELLANEOUS
    GCN 34490
    HICL Sequence Number 006619
    HICL Sequence Number Description ATOVAQUONE
    Brand/Generic Brand
    Proprietary Name MEPRON
    Proprietary Name Suffix n/a
    Non-Proprietary Name atovaquone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 750
    Active Ingredient Units mg/5mL
    Substance Name ATOVAQUONE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Antimalarial [EPC], Antiprotozoal [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020500
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0547-00 (00173054700)

    NDC Package Code 0173-0547-00
    Billing NDC 00173054700
    Package 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH
    Marketing Start Date 1998-09-18
    NDC Exclude Flag N
    Pricing Information N/A